SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-136951
Filing Date
2021-11-10
Accepted
2021-11-10 16:15:33
Documents
2
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2132571-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2132571-1_3seq1.xml 3 1652
2 EXHIBIT 24.1 tm2132571d1_ex24-1.htm EX-24.1 10062
  Complete submission text file 0001104659-21-136951.txt   13256
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS INC. 271 WAVERLY OAKS RD., STE 108 WALTHAM MA 02452
Business Address
Daniels Eric Joseph (Reporting) CIK: 0001892943 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 211396802